Zobrazeno 1 - 10
of 34
pro vyhledávání: '"E A, Sabelnikova"'
Autor:
A. I. Parfenov, O. V. Akhmadullina, N. I. Belostotsky, E. A. Sabelnikova, A. A. Novikov, S. V. Bykova, S. R. Dbar
Publikováno v:
Терапевтический архив, Vol 93, Iss 2, Pp 129-137 (2021)
The article describes enteropathy with impaired membrane digestion (EIMD) as a new nosological form. The main clinical manifestation of EIMD is the poor tolerance of food products, in particular carbohydrates and a decrease in the activity of membran
Externí odkaz:
https://doaj.org/article/1b44825614a841e2a95e38c4dd9b4e67
Autor:
O. V. Knyazev, M. Yu. Zvyaglova, A. V. Kagramanova, I. A. Li, E. A. Sabelnikova, A. A. Lishchinskaya, D. S. Kulakov, A. I. Parfenov
Publikováno v:
Терапевтический архив, Vol 93, Iss 2, Pp 150-157 (2021)
Aim. To define the frequency of adverse events and loss of the response in patients with ulcerative colitis (UC) and Crohns disease (CD), treated with original medicine infliximab (IFX) Remicaide and its biosimilars. Materials and methods. We incl
Externí odkaz:
https://doaj.org/article/7b2a05de304e4187a8a9f0dd6dd2c75c
Publikováno v:
Терапевтический архив, Vol 92, Iss 12, Pp 36-42 (2020)
The current concepts of the short bowel syndrome and malabsorption after intestinal surgery are generally accepted, but do not fully reflect the patients condition, making it difficult to diagnose and treat it. Aim.The purpose of the study is to a
Externí odkaz:
https://doaj.org/article/b8d70f6f80604f67b6807c9904112d43
Publikováno v:
Терапевтический архив, Vol 92, Iss 2, Pp 93-96 (2020)
Bile acids were first considered carcinogenic in 1939. Since then, accumulated data have associated colon cell changes with high levels of bile acids as an important risk factor for developing colorectal cancer, which is more common among people who
Externí odkaz:
https://doaj.org/article/a1c104b8938e4ae3a5242369b2aec6a0
Autor:
A I Parfenov, N I Belostotsky, S G Khomeriki, O V Akhmadullina, S V Bykova, E A Sabelnikova, S R Dbar
Publikováno v:
Терапевтический архив, Vol 91, Iss 2, Pp 25-31 (2019)
Aim. To evaluate the effectiveness of enteroprotector Rebamipide in the treatment of enteropathy with impaired membrane digestion (EIMD). Materials and methods. We examined 102 patients aged 18 to 50 years (41 men and 61 women) with clinical signs of
Externí odkaz:
https://doaj.org/article/f4a65b83dbe447f98669ee84931b9b5a
Autor:
L M Krums, S V Bykova, E A Sabelnikova, Ts V Aminova, N I Poleva, R B Gudkov, M B Turaeva, A I Parfenov
Publikováno v:
Терапевтический архив, Vol 90, Iss 10, Pp 89-93 (2018)
A clinical observation of a patient with celiac disease, aged 23, with severe form of osteoporosis, accompanied by atraumatic fractures bones, lameness, late onset of menstruation and pathology of pregnancy is described. It is emphasized that only a
Externí odkaz:
https://doaj.org/article/d12459b61bc343f7a9d446ce30bdb2eb
Publikováno v:
Терапевтический архив, Vol 90, Iss 2, Pp 43-46 (2018)
The article presents the results of examination of 32 patients with common variable immune deficiency (barn) with involvement in the pathological process of the digestive system. The features of the clinical picture, the content of immunoglobulins in
Externí odkaz:
https://doaj.org/article/758a601b2ddb4c15b10674ef3d396e93
Autor:
O. V. Knyazev, A. V. Kagramanova, A. А. Lischinskaya, I. А. Li, E. А. Sabelnikova, A. N. Demchenko, B. А. Nanaeva, E. Yu. Zhulina, N. V. Kamzarakova, M. V. Chebotareva, N. А. Fadeeva, K. А. Nikolskaya
Publikováno v:
Meditsinskiy sovet = Medical Council. :105-116
Introduction.The results of registrational clinical trials (CTs) and real clinical practice do not always correlate. The task of practitioners is to find optimal approaches to the therapy of Crohn’s disease, based on the analysis of clinical trials
Publikováno v:
Терапевтический архив, Vol 89, Iss 12-2, Pp 144-149 (2017)
The paper gives information on the classification, pathogenesis, and clinical manifestations of short bowel syndrome following after intestinal resection. It discusses the treatment and rehabilitation of patients with this condition.
Externí odkaz:
https://doaj.org/article/208bc730427045dcaee702a4c75e4492
Autor:
A I Parfenov, O V Akhmadullina, E A Sabelnikova, N I Belostotsky, M V Kirova, S G Khomeriki, S V Bykova
Publikováno v:
Терапевтический архив, Vol 89, Iss 4, Pp 45-52 (2017)
Aim. To elucidate the role of intestinal carbohydrases (glucoamylase, maltase, sucrose, and lactase) in the etiology and pathogenesis of functional bowel diseases (FBD). Subjects and methods. 74 patients (36 men and 38 women) aged 18 to 50 years with
Externí odkaz:
https://doaj.org/article/96aa352ccf2c4456b2babfe70b47ae59